K203193: BD Intraosseous Infusion System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K203193 (BD Intraosseous Infusion System, cleared 2021-03-04 for Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K203193
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK203193
Cleared Device Trade / Generic NameBD Intraosseous Infusion System
FDA Applicant on FilingBard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]
FDA 3-Letter Product ClassificationProduct Code MHC
FDA Substantial Equivalence Decision Date2021-03-04
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd], compare peer devices under FDA Product Code MHC, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.